Hemispherx BioPharma (HEB)

[Investor100]

Solid Interview w/CEO Carter

Spoke with conviction and complete understanding of his products without question.

( former professor at MIT- no dummy running the show )

He states that 80% approval at this stage of FDA approval however does not have a time frame as to when FDA might make their announcement.

Ramping up production at its manufacturing facility for possible production request for both CFS and H1N1 potential opportunity.

Expanding and increasing staff to be announced next week with much excitement.

Raising 150M shelf offering to be prepared for strategic relationships / alliances and expansion of products an production...interesting!

Well informed with relationship with Japanese government who solicited HEB for assistance not vice-versa.

I have and continue to be convinced that the future looks strong @ HEB so I am staying the course with my holdings.

GLTA

Investor 100